对《转移性非小细胞肺癌：ESMO诊断、治疗及随访临床实践指南》的勘误 - Suppr

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".

作者信息

Planchard D, Popat S, Kerr K, Novello S, Smit E F, Faivre-Finn C, Mok T S, Reck M, Van Schil P E, Hellmann M D, Peters S

出版信息

Ann Oncol. 2019 May;30(5):863-870. doi: 10.1093/annonc/mdy474. Epub 2019 Dec 4.

DOI:10.1093/annonc/mdy474

PMID:31987360

Abstract

摘要

相似文献

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".对《转移性非小细胞肺癌：ESMO诊断、治疗及随访临床实践指南》的勘误

Ann Oncol. 2019 May;30(5):863-870. doi: 10.1093/annonc/mdy474. Epub 2019 Dec 4.

Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.泛亚地区调整的 ESMO 临床实践指南：局部晚期不可切除的非小细胞肺癌患者管理：一项由 KSMO-ESMO 发起、CSCO、ISMPO、JSMO、MOS、SSO 和 TOS 支持的倡议。

Ann Oncol. 2020 Feb;31(2):191-201. doi: 10.1016/j.annonc.2019.10.026. Epub 2019 Dec 20.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌：ESMO诊断、治疗及随访临床实践指南

Ann Oncol. 2016 Sep;27(suppl 5):v1-v27. doi: 10.1093/annonc/mdw326.

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌（NSCLC）：ESMO诊断、治疗及随访临床实践指南

Ann Oncol. 2014 Sep;25 Suppl 3:iii27-39. doi: 10.1093/annonc/mdu199. Epub 2014 Aug 11.

Analyzing the clinical benefit of newer therapies for advanced or metastatic non-small-cell lung cancer: application of the ESMO-magnitude of clinical benefit scale v1.1.分析新型疗法对晚期或转移性非小细胞肺癌的临床获益：应用 ESMO 临床获益量表 v1.1。

Acta Oncol. 2021 Sep;60(9):1225-1232. doi: 10.1080/0284186X.2021.1942546. Epub 2021 Jun 29.

Ann Oncol. 2012 Oct;23 Suppl 7:vii56-64. doi: 10.1093/annonc/mds226.

Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.早期及局部晚期（非转移性）非小细胞肺癌：ESMO临床诊断、治疗及随访实践指南

Ann Oncol. 2010 May;21 Suppl 5:v103-15. doi: 10.1093/annonc/mdq207.

Use of adjuvant chemotherapy (CT) and radiotherapy (RT) in incompletely resected (R1) early stage Non-Small Cell Lung Cancer (NSCLC): a European survey conducted by the European Society for Medical Oncology (ESMO) young oncologists committee.辅助化疗（CT）和放疗（RT）在未完全切除（R1）的早期非小细胞肺癌（NSCLC）中的应用：欧洲医学肿瘤学会（ESMO）青年肿瘤学家委员会进行的一项欧洲调查。

Lung Cancer. 2014 Jul;85(1):74-80. doi: 10.1016/j.lungcan.2014.03.010. Epub 2014 Mar 16.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.转移性非小细胞肺癌：欧洲肿瘤内科学会临床实践诊断、治疗及随访指南

Ann Oncol. 2010 May;21 Suppl 5:v116-9. doi: 10.1093/annonc/mdq189.

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up.第二届 ESMO 肺癌共识会议：早期非小细胞肺癌诊断、治疗和随访共识。

Ann Oncol. 2014 Aug;25(8):1462-74. doi: 10.1093/annonc/mdu089. Epub 2014 Feb 20.

引用本文的文献

Arterial and venous thromboembolic events in patients with cancer treated with targeted therapies: a population-based cohort study.接受靶向治疗的癌症患者的动脉和静脉血栓栓塞事件：一项基于人群的队列研究。

EClinicalMedicine. 2025 Aug 21;87:103440. doi: 10.1016/j.eclinm.2025.103440. eCollection 2025 Sep.

Noninvasive Prediction of Programmed Cell Death Protein-Ligand 1 Expression in Locally Advanced Non-small Cell Lung Cancer by F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography-Based Metabolic Habitats: A Multicenter Radiomic and Biological Study.基于F-氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描代谢特征对局部晚期非小细胞肺癌程序性细胞死亡蛋白配体1表达的无创预测：一项多中心放射组学和生物学研究

Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18139-2.

A Critical Review of Immunomodulation in the Management of Inoperable Stage III NSCLC.不可切除Ⅲ期非小细胞肺癌治疗中免疫调节的批判性综述

Cancers (Basel). 2025 May 30;17(11):1829. doi: 10.3390/cancers17111829.

Exploring cellular plasticity and resistance mechanisms in lung cancer: Innovations and emerging therapies.探索肺癌中的细胞可塑性和耐药机制：创新与新兴疗法

J Pharm Anal. 2025 May;15(5):101179. doi: 10.1016/j.jpha.2024.101179. Epub 2025 Jan 3.

Single-cell multimodal analysis reveals tumor microenvironment predictive of treatment response in non-small cell lung cancer.单细胞多组学分析揭示了可预测非小细胞肺癌治疗反应的肿瘤微环境。

Sci Adv. 2025 May 23;11(21):eadu2151. doi: 10.1126/sciadv.adu2151.

A prognostic signature of Glutathione metabolism-associated long non-coding RNAs for lung adenocarcinoma with immune microenvironment insights.一种与谷胱甘肽代谢相关的长链非编码RNA对肺腺癌的预后特征及免疫微环境洞察

Front Immunol. 2025 Feb 10;16:1477437. doi: 10.3389/fimmu.2025.1477437. eCollection 2025.

Very Early Health Technology Assessment for Potential Predictive Biomarkers in the Treatment of Advanced Non-Small Cell Lung Cancer.晚期非小细胞肺癌治疗中潜在预测生物标志物的超早期卫生技术评估

Pharmacoecon Open. 2025 May;9(3):471-485. doi: 10.1007/s41669-025-00557-3. Epub 2025 Jan 28.

Progressive Disease with Mixed Response After Immunotherapy in Non-Small Cell Lung Cancer.非小细胞肺癌免疫治疗后出现混合反应的疾病进展

J Inflamm Res. 2024 Sep 11;17:6317-6327. doi: 10.2147/JIR.S477244. eCollection 2024.

Radiomics nomogram for predicting chemo-immunotherapy efficiency in advanced non-small cell lung cancer.放射组学列线图预测晚期非小细胞肺癌的化疗免疫治疗效果。

Sci Rep. 2024 Sep 6;14(1):20788. doi: 10.1038/s41598-024-63415-y.

Plasma lipidomics profiling in predicting the chemo-immunotherapy response in advanced non-small cell lung cancer.血浆脂质组学分析在预测晚期非小细胞肺癌化疗免疫治疗反应中的应用

Front Oncol. 2024 Jul 8;14:1348164. doi: 10.3389/fonc.2024.1348164. eCollection 2024.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: "Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up".

作者信息

出版信息

相似文献

引用本文的文献

文献检索

文件翻译

深度研究

Suppr 超能文献

相似文献

引用本文的文献